NDC 0053-7202

ZEMAIRA

.alpha.1-proteinase Inhibitor Human

ZEMAIRA is a Kit in the Plasma Derivative category. It is labeled and distributed by Csl Behring Llc. The primary component is .

Product ID0053-7202_44e7244d-0e34-4b42-9ae8-a6ddb0352abf
NDC0053-7202
Product TypePlasma Derivative
Proprietary NameZEMAIRA
Generic Name.alpha.1-proteinase Inhibitor Human
Dosage FormKit
Marketing Start Date2019-04-24
Marketing CategoryBLA / BLA
Application NumberBLA125078
Labeler NameCSL Behring LLC
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0053-7202-02

1 KIT in 1 CARTON (0053-7202-02) * 76 mL in 1 VIAL, SINGLE-USE (0053-7212-01) * 76 mL in 1 VIAL, SINGLE-USE (0053-7653-80)
Marketing Start Date2019-04-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0053-7202-02 [00053720202]

ZEMAIRA KIT
Marketing CategoryBLA
Application NumberBLA125078
Product TypePLASMA DERIVATIVE
Marketing Start Date2019-04-24

Drug Details

NDC Crossover Matching brand name "ZEMAIRA" or generic name ".alpha.1-proteinase Inhibitor Human"

NDCBrand NameGeneric Name
0053-7201Zemairaalpha-1-proteinase inhibitor human
0053-7202ZEMAIRA.ALPHA.1-PROTEINASE INHIBITOR HUMAN
0053-7203ZEMAIRA.ALPHA.1-PROTEINASE INHIBITOR HUMAN
0944-2884GLASSIA.ALPHA.1-PROTEINASE INHIBITOR HUMAN

Trademark Results [ZEMAIRA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ZEMAIRA
ZEMAIRA
78087711 2841496 Live/Registered
CSL BEHRING L.L.C.
2001-10-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.